Tsan-Zon Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tsan-Zon Liu has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Arnold Stern
Department of Pharmacology, New York University Medical Center, New York, NY, USA
5 shared publicationsDaniel Tsun-Yee Chiu
School of Medical Technology and Graduate Institute of Medical Biotechnology, Chang Gung University, Kwei-Shan, Taoyuan, Taiwan
4 shared publicationsChi-Liang Chern
Basic Medical Science Education Center, Fooyin University, Kaohsiung County 831, Taiwan, Department of Medical Technology, Fooyin University, Ta-Liao, Kaohsiung 831, Taiwan, and Center for Gerontological Research and Graduate Institute of Medical Biotechnology, Chang Gung University, Kwei-Shan, Taoyuan 333, Taiwan, Republic of China
3 shared publicationsChin-Hung Tsai
Chung-Hwa Institute of Technology
3 shared publicationsJeng-Shu Wei
3 shared publicationsChih-Hsiung Wu
College of Medicine, Taipei Medical University
2 shared publications
Latest Publications
- 1 July 2012
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 20 (4) , 381-385
Overexpression of GRP78 Is Associated With Malignant Transformation in Epithelial Ovarian Tumors
Glucose-regulated protein 78 (GRP78) is one of the best-characterized endoplasmic reticulum chaperone proteins. The aim of this study was to explore the potential implications of GRP78 in the development of epithelial ovarian carcinomas (EOCs) and the possible clinical usefulness of GRP78 expression as a prognostic biomarker for EOCs. A total of 133 women were enrolled. This pilot study consisted of 96 cases of EOCs and 37 cases of benign ovarian tumors as controls. The expression of GRP78 protein was studied using tissue microarray technology and immunohistochemistry. Of the 96 invasive carcinomas analyzed, 25 cases (26.0%) showed moderate GRP78 expression and 65 cases (67.7%) showed strong GRP78 expression. Conversely, 17 (45.9%) of the 37 patients with benign ovarian tumors showed no or weak GRP78 staining. Our results demonstrated that GRP78 expression was significantly higher in EOCs than in benign ovarian tumors (P<0.001). However, no statistically significant association was found between GRP78 expression and survival. The present study suggests that GRP78 plays a significant role in malignant transformation of epithelial ovarian tumors and may represent an important biomarker for EOCs.
- 1 July 2012
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 20 (4) , 381-385
Overexpression of GRP78 Is Associated With Malignant Transformation in Epithelial Ovarian Tumors
Glucose-regulated protein 78 (GRP78) is one of the best-characterized endoplasmic reticulum chaperone proteins. The aim of this study was to explore the potential implications of GRP78 in the development of epithelial ovarian carcinomas (EOCs) and the possible clinical usefulness of GRP78 expression as a prognostic biomarker for EOCs. A total of 133 women were enrolled. This pilot study consisted of 96 cases of EOCs and 37 cases of benign ovarian tumors as controls. The expression of GRP78 protein was studied using tissue microarray technology and immunohistochemistry. Of the 96 invasive carcinomas analyzed, 25 cases (26.0%) showed moderate GRP78 expression and 65 cases (67.7%) showed strong GRP78 expression. Conversely, 17 (45.9%) of the 37 patients with benign ovarian tumors showed no or weak GRP78 staining. Our results demonstrated that GRP78 expression was significantly higher in EOCs than in benign ovarian tumors (P<0.001). However, no statistically significant association was found between GRP78 expression and survival. The present study suggests that GRP78 plays a significant role in malignant transformation of epithelial ovarian tumors and may represent an important biomarker for EOCs.
- 23 February 2011
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (8) , 2395-2403
Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma
Glucose-regulated protein 78 (GRP78) plays an important role in the therapeutic treatment and progression of cancer. However, little is known about the effect of GRP78 expression to curcumin in hepatocellular carcinoma (HCC). In this study, we generated GRP78 knockdown cells (GRP78KD) by a short interfering RNA (siRNA) technique. The antiproliferation effects of curcumin were determined by MTT assay, TUNEL assay, and cell cycle determination. We found that GRP78KD cells were more resistant to curcumin treatment compared with the parental cells in MTT assay. The apoptosis cell population was increased in scrambled-siRNA cells treated with curcumin compared with GRP78KD cells in cell cycle distribution and TUNEL assays. Finally, we found that knocking down GRP78 causes resistance to curcumin treatment through the suppression of caspase-3 and caspase-8 expression levels. We conclude that the expression level of GRP78 may contribute to the therapeutic effect of curcumin on HCC cells.
- 23 February 2011
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (8) , 2395-2403
Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma
Glucose-regulated protein 78 (GRP78) plays an important role in the therapeutic treatment and progression of cancer. However, little is known about the effect of GRP78 expression to curcumin in hepatocellular carcinoma (HCC). In this study, we generated GRP78 knockdown cells (GRP78KD) by a short interfering RNA (siRNA) technique. The antiproliferation effects of curcumin were determined by MTT assay, TUNEL assay, and cell cycle determination. We found that GRP78KD cells were more resistant to curcumin treatment compared with the parental cells in MTT assay. The apoptosis cell population was increased in scrambled-siRNA cells treated with curcumin compared with GRP78KD cells in cell cycle distribution and TUNEL assays. Finally, we found that knocking down GRP78 causes resistance to curcumin treatment through the suppression of caspase-3 and caspase-8 expression levels. We conclude that the expression level of GRP78 may contribute to the therapeutic effect of curcumin on HCC cells.
- 1 February 2010
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 109 (2) , 106-112
Is the Blood Donated by Habitual Nut Quid Chewers Suitable for Use in Transfusion?
- 1 February 2010
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 109 (2) , 106-112
Is the Blood Donated by Habitual Nut Quid Chewers Suitable for Use in Transfusion?
- 20 January 2010
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (6) , 1703-1709
Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
GRP78 plays an essential role in embryonic development and in the therapeutic treatment and progression of cancer. However, little is known about the role of GRP78 in hepatocellular carcinoma (HCC). In this study, we characterized five different HCC cell lines to examine GRP78 expression patterns and found that only HepJ5 cells ectopically overexpress GRP78. We knocked down GRP78 expression in HepJ5 cells using a small interfering RNA (siRNA), and the proliferation assay and migration assay were performed. Using siRNA technique, we could successfully reduce GRP78 expression levels in HepJ5 cells. In a cell growth study, we found that GRP78-siRNA caused no significant changes in cellular proliferation in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation, and cell cycle distribution. In a cell migration study, we found that GRP78-siRNA HepJ5 cells had dramatically increased migration ability in Transwell assay. We conclude that ectopically expressed GRP78 does not contribute to the increased proliferation of HepJ5 cells, but does correlate with the migration of HCC cells under normoxic conditions.
- 20 January 2010
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (6) , 1703-1709
Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
GRP78 plays an essential role in embryonic development and in the therapeutic treatment and progression of cancer. However, little is known about the role of GRP78 in hepatocellular carcinoma (HCC). In this study, we characterized five different HCC cell lines to examine GRP78 expression patterns and found that only HepJ5 cells ectopically overexpress GRP78. We knocked down GRP78 expression in HepJ5 cells using a small interfering RNA (siRNA), and the proliferation assay and migration assay were performed. Using siRNA technique, we could successfully reduce GRP78 expression levels in HepJ5 cells. In a cell growth study, we found that GRP78-siRNA caused no significant changes in cellular proliferation in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation, and cell cycle distribution. In a cell migration study, we found that GRP78-siRNA HepJ5 cells had dramatically increased migration ability in Transwell assay. We conclude that ectopically expressed GRP78 does not contribute to the increased proliferation of HepJ5 cells, but does correlate with the migration of HCC cells under normoxic conditions.
- 30 September 2007
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 15 (2) , 183-196
Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-κB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells
Hyperhomocysteinemia is associated with dysfunction and an independent risk factor of cardiovascular diseases. Cholestin (Monascus purpureus-fermented rice), contains a naturally-occurring statin, which has lipid-modulating and anti-inflammatory effects. We investigated the effects of Cholestin extract on the expression of vascular cell adhesion molecule-1 (VCAM-1) by homocysteine (HCY)-treated human aortic endothelial cells (HAECs). Supplement of HAECs with Cholestin extract significantly suppressed cellular binding between the human monocytic cells U937 and HCY-stimulated HAECs. Quantitative PCR and immunoblot analysis showed that Cholestin extract significantly attenuated HCY-induced expression of VCAM-1 mRNA and protein, respectively. Gel shift assays showed that Cholestin treatment reduced HCY-activated transcription factor nuclear factor-κB (NF-κB). Furthermore, Cholestin also attenuated reactive oxygen species (ROS) generation in vitro and in HCY-treated HAECs. Supplement with statins including simvastatin and parastatin gave similar results as compared with Cholestin. In conclusion, Cholestin reduces HCY-stimulated endothelial adhesiveness as well as downregulating intracellular ROS formation, NF-κB activation, and VCAM-1 expression in HAECs, supporting the notion that the natural compound Cholestin may have potential implications in clinical atherosclerosis disease.
- 30 September 2007
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 15 (2) , 183-196
Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-κB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells
Hyperhomocysteinemia is associated with dysfunction and an independent risk factor of cardiovascular diseases. Cholestin (Monascus purpureus-fermented rice), contains a naturally-occurring statin, which has lipid-modulating and anti-inflammatory effects. We investigated the effects of Cholestin extract on the expression of vascular cell adhesion molecule-1 (VCAM-1) by homocysteine (HCY)-treated human aortic endothelial cells (HAECs). Supplement of HAECs with Cholestin extract significantly suppressed cellular binding between the human monocytic cells U937 and HCY-stimulated HAECs. Quantitative PCR and immunoblot analysis showed that Cholestin extract significantly attenuated HCY-induced expression of VCAM-1 mRNA and protein, respectively. Gel shift assays showed that Cholestin treatment reduced HCY-activated transcription factor nuclear factor-κB (NF-κB). Furthermore, Cholestin also attenuated reactive oxygen species (ROS) generation in vitro and in HCY-treated HAECs. Supplement with statins including simvastatin and parastatin gave similar results as compared with Cholestin. In conclusion, Cholestin reduces HCY-stimulated endothelial adhesiveness as well as downregulating intracellular ROS formation, NF-κB activation, and VCAM-1 expression in HAECs, supporting the notion that the natural compound Cholestin may have potential implications in clinical atherosclerosis disease.
- 1 August 2006
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 44 (8) , 1399-1407
Sevoflurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils
- 1 August 2006
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 44 (8) , 1399-1407
Sevoflurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils
- 1 November 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (11) , 1942-1946
Annoglabayin, a Novel Dimeric Kaurane Diterpenoid, and Apoptosis in Hep G2 Cells of Annomontacin from the Fruits of Annona glabra
Annoglabayin (1), a novel Annona dimeric kaurane diterpenoid, has been isolated from Annona glabra, and its structure was determined on the basis of spectroscopic analysis. Annoglabayin (1) contains a unique carbon bridge between two nor-ent-kaurane monomeric units. The dose−response of 2 in Hep G2 cells indicated that 2 increased DNA damage. In addition, our results showed that 2 induced a noticeable decrease in mitochondrial transmembrane potential during treatment. These results indicate that 2 produces apoptotic events in Hep G2 cells, through inducing changes in mitochondria.
- 1 November 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (11) , 1942-1946
Annoglabayin, a Novel Dimeric Kaurane Diterpenoid, and Apoptosis in Hep G2 Cells of Annomontacin from the Fruits of Annona glabra
Annoglabayin (1), a novel Annona dimeric kaurane diterpenoid, has been isolated from Annona glabra, and its structure was determined on the basis of spectroscopic analysis. Annoglabayin (1) contains a unique carbon bridge between two nor-ent-kaurane monomeric units. The dose−response of 2 in Hep G2 cells indicated that 2 increased DNA damage. In addition, our results showed that 2 induced a noticeable decrease in mitochondrial transmembrane potential during treatment. These results indicate that 2 produces apoptotic events in Hep G2 cells, through inducing changes in mitochondria.
- 1 July 2004
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 11 (5) , 692-696
Evidence that high-doseL-arginine may be inappropriate for use by diabetic patients as a prophylactic blocker of methylglyoxal glycation
Previous reports have suggested that high-doseL-arginine could be used in diabetic patients as a prophylactic blocker for the initial glycation reaction of proteins by methylglyoxal (MG), a reactive dicarbonyl compound of glucose metabolism. Here, we present several lines of evidence to substantiate that this prophylactic intervention may be inappropriate and should be used with care. First, we demonstrated that when various concentrations ofL-arginine (2.0–8.0 mM) were added to a fixed concentration of MG (1.56 µM) in a buffered lucigenin solution, dose-dependent generation of superoxide anion (O 2 − )-mediated ultraweak chemiluminescence (uwCL) occurs. The suppression of uwCL generation by exogenously added superoxide dismutase further substantiated that the interaction between MG andL-arginine generated O 2 − . This phenomenon can also be demonstrated in a serum-based system. Furthermore, when a fixed concentration ofL-arginine (8.0 mM) was added exogenously to a group of sera obtained from either diabetic patients (n=10) or their matched nondiabetic controls (n=10), a marked discrepancy in the generation of O 2 − -mediated uwCL could be demonstrated (12,534 ± 3,147 vs. 950 ± 350 counts; pL-arginine for prophylactic measures in diabetic patients may be questioned, because the inhibition of the glycation reaction between MG and proteins by high-doseL-arginine unexpectedly produces plethoric O 2 − as a by-product, which may subsequently aggravate the preexisting oxidative stress status of diabetic patients.
- 1 July 2004
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 11 (5) , 692-696
Evidence that high-doseL-arginine may be inappropriate for use by diabetic patients as a prophylactic blocker of methylglyoxal glycation
Previous reports have suggested that high-doseL-arginine could be used in diabetic patients as a prophylactic blocker for the initial glycation reaction of proteins by methylglyoxal (MG), a reactive dicarbonyl compound of glucose metabolism. Here, we present several lines of evidence to substantiate that this prophylactic intervention may be inappropriate and should be used with care. First, we demonstrated that when various concentrations ofL-arginine (2.0–8.0 mM) were added to a fixed concentration of MG (1.56 µM) in a buffered lucigenin solution, dose-dependent generation of superoxide anion (O 2 − )-mediated ultraweak chemiluminescence (uwCL) occurs. The suppression of uwCL generation by exogenously added superoxide dismutase further substantiated that the interaction between MG andL-arginine generated O 2 − . This phenomenon can also be demonstrated in a serum-based system. Furthermore, when a fixed concentration ofL-arginine (8.0 mM) was added exogenously to a group of sera obtained from either diabetic patients (n=10) or their matched nondiabetic controls (n=10), a marked discrepancy in the generation of O 2 − -mediated uwCL could be demonstrated (12,534 ± 3,147 vs. 950 ± 350 counts; pL-arginine for prophylactic measures in diabetic patients may be questioned, because the inhibition of the glycation reaction between MG and proteins by high-doseL-arginine unexpectedly produces plethoric O 2 − as a by-product, which may subsequently aggravate the preexisting oxidative stress status of diabetic patients.
- 27 November 2002
- Published by Elsevier in Life Sciences
- Vol. 72 (8) , 909-916
Palladium and platinum ions interfere with the measurement of erythrocyte vesiculation by inhibiting the acetylcholinesterase activity of the released spectrin-depleted microvesicles
- 27 November 2002
- Published by Elsevier in Life Sciences
- Vol. 72 (8) , 909-916
Palladium and platinum ions interfere with the measurement of erythrocyte vesiculation by inhibiting the acetylcholinesterase activity of the released spectrin-depleted microvesicles
- 30 November 2001
- Published by Taylor & Francis in Analytical Letters
- Vol. 34 (14) , 2477-2484
PERIODATE-CATALYZED OXIDATIVE COUPLING OF ANILINE-DERIVEDP-AMINOPHENOL WITHP-XYLENOL AS A DETECTION METHOD FOR HYDROXYL RADICALS
A simple spectrophotometric method for rapid detection of hydroxyl radical (•OH) has been developed. The principle of the method depends upon the hydroxylation of a trapping agent, aniline, by •OH leading to the formation of various hydroxylated products. One of these hydroxylated products, p-aminophenol (PAP), is capable of undergoing an oxidative coupling reaction with p-xylenol (2,5-dimethylphenol) catalyzed by sodium periodate. The resultant indophenol-derivative formed can be measured spectrophotometrically at 635 nm. The net increment of absorbance at 635 nm can then be used to estimate the degree of hydroxylation of aniline, which is dependent upon the amount of •OH present in the assay system. A specific example for estimating the •OH-scavenging abilities of food products is also given.
- 30 November 2001
- Published by Taylor & Francis in Analytical Letters
- Vol. 34 (14) , 2477-2484
PERIODATE-CATALYZED OXIDATIVE COUPLING OF ANILINE-DERIVEDP-AMINOPHENOL WITHP-XYLENOL AS A DETECTION METHOD FOR HYDROXYL RADICALS
A simple spectrophotometric method for rapid detection of hydroxyl radical (•OH) has been developed. The principle of the method depends upon the hydroxylation of a trapping agent, aniline, by •OH leading to the formation of various hydroxylated products. One of these hydroxylated products, p-aminophenol (PAP), is capable of undergoing an oxidative coupling reaction with p-xylenol (2,5-dimethylphenol) catalyzed by sodium periodate. The resultant indophenol-derivative formed can be measured spectrophotometrically at 635 nm. The net increment of absorbance at 635 nm can then be used to estimate the degree of hydroxylation of aniline, which is dependent upon the amount of •OH present in the assay system. A specific example for estimating the •OH-scavenging abilities of food products is also given.